Lv4
500 积分 2025-06-06 加入
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
5天前
已完结
First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction
9天前
已完结
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies
9天前
已完结
Pathogenesis of immune thrombocytopenia
9天前
已完结
Donor-derived CD7 CAR-T in T-ALL/LBL: promise and pitfalls
12天前
已关闭
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
21天前
已完结
Current and emerging therapeutic approaches for T‐cell acute lymphoblastic leukaemia
21天前
已完结
Immune reconstitution after CD7 CAR-T cell therapy for refractory/relapsed acute T-lymphoblastic leukaemia/lymphoblastic lymphoma (R/R T-ALL/LBL)
1个月前
已完结
Immune reconstitution after CD7 CAR-T cell therapy for refractory/relapsed acute T-lymphoblastic leukaemia/lymphoblastic lymphoma (R/R T-ALL/LBL)
1个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
皖公网安备34019202002308
